Cargando…
TNF-α inhibitors in the treatment of hidradenitis suppurativa
Hidradenitis suppurativa (HS) is a complex disease with a dramatic impact on the quality of life of patients that it afflicts. Despite this, there are few treatment options offering long-term relief. The exact pathophysiology of HS is unclear, although the current theory involves follicular obstruct...
Autores principales: | Savage, Kevin T., Flood, Kelsey S., Porter, Martina L., Kimball, Alexa B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540495/ https://www.ncbi.nlm.nih.gov/pubmed/31191873 http://dx.doi.org/10.1177/2040622319851640 |
Ejemplares similares
-
Tofacitinib shows benefit in conjunction with other therapies in recalcitrant hidradenitis suppurativa patients
por: Savage, Kevin T., et al.
Publicado: (2020) -
Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa
por: Savage, Kevin T., et al.
Publicado: (2020) -
Response to: Remission of hidradenitis suppurativa after bariatric surgery
por: Golbari, Nicole Mona, et al.
Publicado: (2018) -
Treatment of hidradenitis suppurativa resolves associated hematologic abnormalities
por: Morss-Walton, Peyton C., et al.
Publicado: (2022) -
33892 Telehealth use at a specialty hidradenitis suppurativa clinic during the COVID-19 pandemic
por: Kim, Diana S., et al.
Publicado: (2022)